These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38018593)
21. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis. Naik MN; Rath S Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342 [TBL] [Abstract][Full Text] [Related]
22. Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings. Son JH; Lim HB; Lee SH; Yang JW; Lee SB PLoS One; 2016; 11(8):e0160897. PubMed ID: 27501044 [TBL] [Abstract][Full Text] [Related]
23. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848 [TBL] [Abstract][Full Text] [Related]
24. Rhino-orbito-cerebral mucormycosis. Raymundo IT; Araújo BG; Costa Cde C; Tavares JP; Lima CG; Nascimento LA Braz J Otorhinolaryngol; 2009; 75(4):619. PubMed ID: 19784435 [No Abstract] [Full Text] [Related]
25. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19. Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509 [TBL] [Abstract][Full Text] [Related]
27. Rhino-Orbital Cerebral Mucormycosis in a Diabetic Patient: An Emergency Medicine Case Report. Sweet R; Hovenden M; Harvey CE; Peterson W; Lott I J Emerg Med; 2023 Mar; 64(3):385-387. PubMed ID: 36932004 [TBL] [Abstract][Full Text] [Related]
28. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases. Santos Gorjón P; Blanco Pérez P; Batuecas Caletrío A; Muñoz Herrera AM; Sánchez González F; de la Fuente Cañibano R Acta Otorrinolaringol Esp; 2010; 61(1):48-53. PubMed ID: 20004878 [TBL] [Abstract][Full Text] [Related]
29. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19. Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India. Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032 [TBL] [Abstract][Full Text] [Related]
31. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India. Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635 [TBL] [Abstract][Full Text] [Related]
32. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
33. [Rhino-orbito-cerebral mucormycosis: two case reports in the light of the literature]. Kara M; Erdoğan H; Toroslu T; Akçalı A; Tatman Okun M; Reşorlu M; Dereköy FS Kulak Burun Bogaz Ihtis Derg; 2015; 25(5):295-301. PubMed ID: 26476519 [TBL] [Abstract][Full Text] [Related]
34. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399 [TBL] [Abstract][Full Text] [Related]
35. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Thajeb P; Thajeb T; Dai D Scand J Infect Dis; 2004; 36(9):643-8. PubMed ID: 15370650 [TBL] [Abstract][Full Text] [Related]
36. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience. Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564 [TBL] [Abstract][Full Text] [Related]
37. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience. Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299 [TBL] [Abstract][Full Text] [Related]